Extracorporeal Albumin Dialysis in Liver Failure with MARS and SPAD: A Randomized Crossover Trial
Conclusion: A simple-to-perform SPAD therapy with equal to MARS dialysate flow parameters provides the same efficacy in bilirubin and bile acid removal. However, clinically relevant endpoints have to be evaluated in randomized trials to compare MARS and SPAD therapies and to define the place of SPAD in the liver failure care program.Blood Purif
Source: Blood Purification - Category: Hematology Source Type: research
More News: Bile | Bilirubin | Dialysis | Hematology | Intensive Care | Liver | Liver Transplant | Statistics | Study | Urology & Nephrology